Please assess the completion status of the following clinical trial:

Trial Title: Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients need to be in a normal sinus rhythm preoperatively.~2. Participants undergoing planned lobectomy and 60 years of age or older or participants undergoing planned pneumonectomy and 18 years of age or older.~3. Planned procedure is 5 days after the start of taking study drugs.~4. Signed written informed consent~5. Women of childbearing potential must have a negative pregnancy test (A woman of childbearing potential is a women who has not been naturally postmenopausal for at least 12 consecutive months or who has not undergone previous surgical sterilization)~6. Adequate liver function evidenced by; aspartate aminotransferase (AST or SGOT) \</= 2.5 \* Upper Limits of Normal (ULN), and alanine aminotransferase (ALT or SGPT) \</= 2.5 \* ULN~Exclusion Criteria:~1. Any history of supraventricular arrhythmia for which the patient is taking medications.~2. Current use of antiarrhythmic medications other than beta-receptor antagonists, calcium-channel antagonists, or digitalis.~3. Use of any supplemental n-3 fatty acids during the previous three months.~4. Use of any statin therapy during the previous three months.~5. Patients known to have a history of recent drug or alcohol abuse.~6. Known allergy to seafood~7. Current use of Gemfibrozil and Fenofibrate.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Atorvastatin (Type: EXPERIMENTAL): 1 Atorvastatin capsule daily plus 3 Placebo capsules twice a day orally, 5 days pre-surgery.
- Fish Oil Supplement (Type: EXPERIMENTAL): 3 Fish Oil capsules twice a day plus 1 Placebo capsule daily orally 5 days pre-surgery.
- Placebo (Type: PLACEBO_COMPARATOR): 4 capsules orally every morning and 3 every evening for 5 days pre-surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).